longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cuprina

CUPR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.19, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 27/45, the industry Median -0.39.

-1.19xP/E
$1.60Stock price
$-1.34Earnings per share
-1.19xP/E
Stock price$1.60Earnings per share$-1.34

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-3.93x
Typical range
-11.98x–-2.23x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
016324864

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
MMEDUSMiniMed
-20.07x146.64%$6.30B
BLCOUSBausch + Lomb
-35.65x94.03%$6.10B
NEOGUSNeogen
-346.41x316.68%$2.74B
ESTAUSEstablishment Labs
-54.53x30.16%$2.12B
XRAYUSDentsply Sirona
-3.70x113.34%$2.02B
KIDSUSOrthopediatrics
-15.22x27.74%$604.44M
CERSUSCerus
-75.17x56.25%$509.86M
SMTIUSSanara Medtech
-10.07x104.59%$322.50M
OSURUSOraSure Tech
-4.89x29.79%$240.01M
RXSTUSRxSight
-4.78x0.68%$224.60M
SKYAUSSkyAI
-0.14x--$56.65M
ZTEKFUSZENTEK LTD
-7.47x--$56.07M
TELAUSTela Bio
-1.29x17.67%$52.98M
XTNTUSXtant Med
-4.03x477.77%$44.89M
NSPRUSInspireMD
-0.68x--$35.80M
RMTIUSRockwell Medical
-6.00x32.67%$31.44M
RVPUSRetractable Tech
-5.65x--$20.36M
LUCYUSInnovative Eyewear
-0.96x--$7.41M
AIDXUS20/20 Biolabs
-0.86x44.74%$6.14M
WOKUSWORK Medical Tech
-0.98x--$4.41M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.